C. Berger et al., PREOPERATIVE RADIOTHERAPY (RT) FOR RECTAL-CANCER - PREDICTIVE FACTORSOF TUMOR DOWNSTAGING AND RESIDUAL TUMOR-CELL DENSITY (RTCD) - PROGNOSTIC IMPLICATIONS, International journal of radiation oncology, biology, physics, 37(3), 1997, pp. 619-627
Citations number
41
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: To determine predictive factors and prognostic value of tumor
downstaging and tumor sterilization after preoperative RT for rectal
cancer. Methods and Materials: Between 1977 and 1994, 167 patients wit
h a histologically proven adenocarcinoma (70 T2, 65 T3, 29 T4, and 3 l
ocal recurrences) underwent preoperative RT. Median dose was 44 Gy (5-
73 Gy). Surgery was performed in a mean time of 5 weeks after RT. Path
ologic specimens have been reviewed by the same pathologist in order t
o specify the modified Astler Coller classification (MAC), and to quan
tify the residual tumor cell density (RTCD). Results: According to the
MAC, there was 9 stage 0 (5%), 10 stage A (6%), 103 stage B1-B3 (62%)
, and 45 stage C1-C3 (27%) tumors. Seventeen percent and 56% of the pa
tients who received a dose greater than or equal to 44 Gy had respecti
vely a 0-A and a B tumor, compared to 4 and 69% in those who received
a dose <44 Gy (p = 0.04). Tumor differentiation and a longer interval
before surgery were significantly associated with a more frequent down
staging, and preoperative staging correlated well to the postoperative
pathological findings. According to the RTCD, 62 tumors (37%) showed
no or only rare foci of residual tumor cells (Group 1); 62 (37%) showe
d an intermediate RTCD (Group 2); and 43 (26%) a high RTCD (Group 3).
No predictive factor of RTCD was statistically significant. In univari
ate analysis, postoperative staging was a significant prognostic facto
r, with corresponding 5-year overall survival rates in 0-A, B, and C s
tages of 92, 67, and 26% (p < 0.01). RTCD was not a prognostic factor.
However, overall and disease-free survival rates for patients with co
mplete pathologic response of 83% at 2 and 5 years suggested a better
outcome in this subgroup of patients. Conclusion: The favorable influe
nce of higher doses of preoperative RT on pathologic stage has been ob
served. Tumor differentiation, preoperative classification and time be
fore surgery were the other predictive factors of tumor downstaging. H
owever, there was no predictive factor of complete pathologic response
. Even after preoperative RT, postoperative staging remained a prognos
tic factor. (C) 1997 Elsevier Science Inc.